Australia markets closed

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.32+0.08 (+1.53%)
At close: 04:00PM EDT
5.00 -0.32 (-6.02%)
After hours: 06:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-6,528
-7,792
-8,224
-8,538
-13,155
Stock-based compensation
944.004
1,128
1,459
1,879
1,629
Change in working capital
-17.584
1,550
132.409
-5,619
4,896
Accounts receivable
-979.19
-48.239
-329.639
-271.882
0
Inventory
-31.053
-192.462
-103.843
20.946
-236.48
Accounts payable
-
655.126
60.284
-527.859
243.356
Other working capital
-5,548
-4,985
-6,596
-12,353
-6,630
Other non-cash items
54.212
129.074
37.025
-105.13
-
Net cash provided by operating activities
-5,548
-4,985
-6,596
-12,353
-6,630
Cash flows from financing activities
Common stock issued
6,718
0
7,444
14,695
3,596
Other financing activities
-
-119.296
-148.993
-1,311
-
Net cash used provided by (used for) financing activities
7,719
-119.296
7,295
13,429
9,035
Net change in cash
2,171
-5,104
698.989
1,076
2,405
Cash at beginning of period
7,006
9,844
9,145
8,069
5,664
Cash at end of period
9,178
4,739
9,844
9,145
8,069
Free cash flow
Operating cash flow
-5,548
-4,985
-6,596
-12,353
-6,630
Free cash flow
-5,548
-4,985
-6,596
-12,353
-6,630